Pain News and Research

Latest Pain News and Research

Cobroxin OTC pain reliever is now available online

Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that its over-the-counter pain reliever, Cobroxin, is available for sale online at Cobroxin.com.

15 Oct 2009

Co-promotion agreement to promote Prosed DS to urologists and retail pharmacists

Timm Medical Technologies, Inc., a specialist Urology company, announced today its exclusive co-promotion agreement with Ferring Pharmaceuticals Inc., a Swiss-based biopharmaceutical company, for Prosed® DS (methenamine, phenyl salicylate, methylene blue, benzoic acid, hyoscyamine sulfate) in the United States.

15 Oct 2009

Foundation for Chiropractic Progress joins 92 national associations in support of World Spine Day

The Foundation for Chiropractic Progress (www.f4cp.com), a not-for-profit organization dedicated to increasing public awareness of the benefits of chiropractic, joins the 92 national associations that are currently members of the World Federation of Chiropractic in support of World Spine Day taking place on October 16, 2009.

15 Oct 2009

Shortage of general surgeons may be linked to higher rate of perforated appendix in rural areas

People who live in rural areas may run a greater risk of having perforated appendix than those in suburban and urban areas, according to a new study out of Dartmouth Medical School, Lebanon, NH. Not having enough general surgeons in rural regions may explain the disparity, according to researchers who presented their findings at the 95th annual Clinical Congress of the American College of Surgeons.

15 Oct 2009

Jazz Pharmaceuticals to present Phase III sodium oxybate trial data at ACR 2009 meetings

Jazz Pharmaceuticals, Inc. announced that data from the company's first Phase III clinical trial of sodium oxybate (JZP-6) for the treatment of fibromyalgia will be presented during the American College of Rheumatology 2009 Annual Meeting (ACR) in Philadelphia, Pennsylvania and also in November during the US Psychiatric and Mental Health Congress (US Psych Congress) in Las Vegas, Nevada.

15 Oct 2009

Progenics Pharmaceuticals and Wyeth Pharmaceuticals sign license agreement

Progenics Pharmaceuticals, Inc. today announced that it has entered into an agreement with Wyeth Pharmaceuticals, a division of Wyeth under which Progenics is regaining all worldwide rights to the RELISTOR® franchise from Wyeth Pharmaceuticals, which Progenics had previously licensed to Wyeth Pharmaceuticals.

14 Oct 2009

CeloNova BioSciences' Embozene Microspheres receives approval

CeloNova BioSciences, Inc. has received approval from its European regulatory body, the British Standards Institution, to expand the list of medical indications for which Embozene(TM) Microspheres may be used and to add a tenth size of the product.

14 Oct 2009

The Regence Foundation unveils signature philanthropic program to access quality palliative care

The Regence Foundation unveiled its signature philanthropic program today, Sojourns, to foster best practices, leadership and collaboration that help people with life-threatening and incurable illness to access quality palliative care in their own community. The Foundation also announced its first Sojourns grant to OHSU Doernbecher Children's Hospital for its Bridges pediatric palliative care program.

14 Oct 2009

Brain researcher finds how the epilepsy and pain drug works

A Duke University Medical Center researcher who spent years looking for the signals that prompt the brain to form new connections between neurons has found one that may explain precisely how a well-known drug for epilepsy and pain actually works.

14 Oct 2009

Telemedicine can optimize trauma care delivery

Telemedicine can help health care providers in rural areas stabilize and treat trauma victims when long distances or inclement weather prevents immediate transfer to an accredited trauma center.

14 Oct 2009

2009 American Cancer Society Pathfinder in Palliative Care awarded to James A. Block

James A. Block, M.D., president of J.A. Block Health Associates, will receive the inaugural 2009 American Cancer Society Pathfinder in Palliative Care Award, which recognizes individuals who have demonstrated innovation and ingenuity in their contributions to the advancement of the field of palliative care.

14 Oct 2009

Studies show that physiotherapy can help relieve symptoms of prostatitis

Prostatitis is no picnic. It is a urological condition which causes infection or inflammation of the prostate gland. It is a fairly common health concern, especially for men under 50 and can seriously affect quality of life including sexuality and intimate relationships. However, new research regarding the benefits of physiotherapy in treating prostititis is promising.

14 Oct 2009

Laser Spine Institute opens medical consultation facilities in Beverly Hills and Fort Lauderdale

After helping thousands of patients get their lives back through minimally invasive endoscopic spine surgery at facilities in Tampa, Scottsdale, and soon in Philadelphia, the Laser Spine Institute (LSI) announces the opening of their newest medical consultation facilities -- in Beverly Hills, Ca., and Fort Lauderdale, Fla., in October -- which aim to meet the growing demand for LSI's spinal procedures and provide greater convenience for local patients.

14 Oct 2009

Epeius Biotechnologies announces clinical study results of tumor-targeted genetic medicine

Epeius Biotechnologies Corporation today announced more stunning results of its pioneering clinical studies of Rexin-G, the world's first and, so far only, tumor-targeted genetic medicine to be validated in the clinic.

14 Oct 2009

Unapproved codeine sulfate tablets: FDA warns four companies to stop marketing

The U.S. Food and Drug Administration today warned four companies that they must stop marketing unapproved codeine sulfate tablets. These drugs are opioid analgesics, commonly called narcotics, that are widely used to treat pain.

14 Oct 2009

Positive results from BioMimetic Therapeutics' Phase III trial comparing Augment Bone Graft to autograft

BioMimetic Therapeutics, Inc. today announced positive top-line results from its North American pivotal (Phase III) randomized controlled trial comparing its fully synthetic, off-the-shelf bone growth factor product, Augment Bone Graft (“Augment”), to autograft for use in hindfoot and ankle fusion surgery.

14 Oct 2009

Endoscopic surgery reduces postoperative discomfort and recovery time

Endoscopic surgery has steadily gained in popularity since it was developed in the 1980s. Dr. Richard Siegfried has teamed with Dr. Louis Quartararo one of only a handful of surgeons who have been trained to perform endoscopic surgery on the spine.

14 Oct 2009

Meda Pharmaceuticals introduces Onsolis for treating breakthrough cancer pain

Meda Pharmaceuticals Inc. today announced the launch of Onsolis(TM)(fentanyl buccal soluble film) in the U.S. for the management of breakthrough pain (BTP) in patients with cancer, eighteen years of age and older, who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.

13 Oct 2009

HyperBranch Medical Technology's NuSeal 30 hernia mesh fixation sealant product receives CE Mark

HyperBranch Medical Technology, Inc. announced today that it has received a CE Mark for its NuSeal 30 hernia mesh fixation sealant product. NuSeal 30 is used in hernia procedures to adhere the mesh. NuSeal 30 provides for secure mesh placement, minimizes pain caused by other fixation devices and gradually degrades as the body heals.

13 Oct 2009

Provectus Pharmaceuticals completes initial treatment in Phase 2 trial of PH-10 for plaque psoriasis

Provectus Pharmaceuticals, Inc., a development stage oncology and dermatology biopharmaceutical company, has completed patient accrual and initial treatment in its Phase 2 trial of PH-10 for the treatment of plaque psoriasis. This milestone marks the third Phase 2 clinical trial for which Provectus has completed patient accrual since May 2009.

13 Oct 2009

Pain News and Research

Latest Pain News and Research

Cobroxin OTC pain reliever is now available online

Co-promotion agreement to promote Prosed DS to urologists and retail pharmacists

Foundation for Chiropractic Progress joins 92 national associations in support of World Spine Day

Shortage of general surgeons may be linked to higher rate of perforated appendix in rural areas

Jazz Pharmaceuticals to present Phase III sodium oxybate trial data at ACR 2009 meetings

Progenics Pharmaceuticals and Wyeth Pharmaceuticals sign license agreement

CeloNova BioSciences' Embozene Microspheres receives approval

The Regence Foundation unveils signature philanthropic program to access quality palliative care

Brain researcher finds how the epilepsy and pain drug works

Telemedicine can optimize trauma care delivery

2009 American Cancer Society Pathfinder in Palliative Care awarded to James A. Block

Studies show that physiotherapy can help relieve symptoms of prostatitis

Laser Spine Institute opens medical consultation facilities in Beverly Hills and Fort Lauderdale

Epeius Biotechnologies announces clinical study results of tumor-targeted genetic medicine

Unapproved codeine sulfate tablets: FDA warns four companies to stop marketing

Positive results from BioMimetic Therapeutics' Phase III trial comparing Augment Bone Graft to autograft

Endoscopic surgery reduces postoperative discomfort and recovery time

Meda Pharmaceuticals introduces Onsolis for treating breakthrough cancer pain

HyperBranch Medical Technology's NuSeal 30 hernia mesh fixation sealant product receives CE Mark

Provectus Pharmaceuticals completes initial treatment in Phase 2 trial of PH-10 for plaque psoriasis

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Pain News and Research

Latest Pain News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in